ArticleRSC advances2020

Ameliorating amyloid aggregation through osmolytes as a probable therapeutic molecule against Alzheimer's disease and type 2 diabetes.

Anchala Kumari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.